Analytical Data
-
Gene name
BE2S1
- Application
-
Alternative Names
BE2S1；2S sulfur-rich seed storage Protein 1
-
Species
E.coli
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P04403
-
Expression Region
37-142aa
-
AA Sequence
QEECREQMQRQQMLSHCRMYMRQQMEESPYQTMPRRGMEPHMSECCEQLEGMDESCRCEGLRMMMMRMQQEEMQPRGEQMRRMMRLAENIPSRCNLSPMRCPMGGS
-
Molecular Weight
14.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BE2S1 is a recombinant protein that has garnered significant attention in recent research due to its potential applications in various fields, including medicine and biotechnology. This protein is derived from the BE2 cell line, which is known for its relevance in neuroblastoma studies. Neuroblastoma, a malignant tumor primarily affecting children, poses challenges in diagnosis and treatment, making it crucial to explore novel therapeutic strategies. The recombinant production of BE2S1 allows for detailed investigations into its structure and function, providing insights into how it may interact with cellular pathways involved in tumorigenesis. Moreover, studies have suggested that BE2S1 may play a role in modulating immune responses, which opens avenues for its application in immunotherapy. Understanding the biochemical properties of BE2S1, including its stability and interaction with other biomolecules, is essential for developing advanced treatment methodologies. Consequently, the synthesis and characterization of this recombinant protein not only enhance our knowledge of neuroblastoma biology but also contribute to innovative strategies in cancer research and therapeutic development.
